secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sage Therapeutics, Inc. (—)
CIK:        0001597553
Form:       8-K
Filed at:   2023-06-16T23:59:59+00:00
Accession:  0001193125-23-168975
Event type: other
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sage Therapeutics stockholders approve ESPP share increase and bylaw amendments at annual meeting
--------------------------------------------------------------------------------

- Stockholders approved 500,000-share increase to the 2014 ESPP, effective immediately.
- Bylaws amended to add universal proxy rules, emergency provisions, and technical updates.
- Directors elected: Michael F. Cola, Barry E. Greene, Jeffrey M. Jonas, M.D., Jessica J. Federer as Class III.
- Ratified PricewaterhouseCoopers LLP as independent auditor for fiscal year ending Dec 31, 2023.
- Advisory vote on executive compensation passed with 39,995,146 for (77.5%) vs 11,173,607 against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1597553/000119312523168975/0001193125-23-168975-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1597553/000119312523168975/d522465d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-168975

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer